Baker Ellis Asset Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-400
Closed -$105K 175
2020
Q2
$105K Buy
+400
New +$107K 0.03% 186
2020
Q1
Sell
-400
Closed -$121K 193
2019
Q4
$121K Buy
+400
New +$110K 0.03% 201
2019
Q3
Sell
-407
Closed -$115K 237
2019
Q2
$115K Buy
+407
New +$111K 0.03% 215

Other funds holding ELV

Baker Ellis Asset Management's ELV Position: Q3 2020 in Review

Baker Ellis Asset Management sold out of Elevance Health (ELV) in Q3 2020, closing a stake of 400 shares — an estimated $105K sold.

Baker Ellis Asset Management first reported a position in ELV in Q2 2019 and held it in 3 quarters. The position peaked at $121K in Q4 2019. 1,094 funds tracked by Wall St. Rank hold ELV as of Q3 2020.

  • Baker Ellis Asset Management reported no remaining Elevance Health position as of Q3 2020 after selling out during the quarter.
  • Baker Ellis Asset Management sold 400 Elevance Health shares in Q3 2020, an estimated $105K.
  • Baker Ellis Asset Management first reported a position in Elevance Health in Q2 2019 and held it in 3 quarters.
  • Baker Ellis Asset Management's Elevance Health position peaked at $121K in Q4 2019.
  • 1,094 funds tracked by Wall St. Rank held Elevance Health as of Q3 2020.

Based on Baker Ellis Asset Management's 13F filing for Q3 2020, filed 13 Nov 2020.